Study of FFI-1010 in Pediatric Kidney Disease

• Status: Completed
• Trial end date: 2019-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is revealing that the ratio of creatinine clearance (Ccr) to inulin clearance (Cin) measuring at the same time is more than 1.2.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fuji Yakuhin Co., Ltd.

Criteria

Inclusion Criteria:

• Kidney disease patients requiring exact evaluation of kidney function

• eGFR: >=30 and <=89 mL/min/1.73m^2

Exclusion Criteria:

• Edema on the day before start of study treatment

• Oliguria on the day before start of study treatment

• Dehydration on the day before start of study treatment

• Infection or inflammatory disease before administration

• History of epilepsy or organic brain disorder

• History of, clinically significant cardiac, hematologic, hepatic and pancreatic disease